Product Information
LOXAPINE 5 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.2949 per EA under NDC 00591036901. Its NADAC has been published 600 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591036901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LOXAPINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA072204On Market Since
6/15/1988
Price Statistics
The NADAC for LOXAPINE 5 MG CAPSULE has been published 600 times since Nov 28, 2013, and over the history we have for it it has declined 11.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2949 per EA |
|---|---|
| All-time high | $0.5044 (Dec 13, 2023) |
| All-time low | $0.2375 (Jan 22, 2025) |
| 52-week high | $0.4135 |
| 52-week low | $0.2949 |
| Median price | $0.3527 |
| Average price | $0.3673 |
| Largest weekly change | +34.3% (Jan 19, 2022) |
| Weeks tracked | 600 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LOXAPINE 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOXAPINE 5 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.2949 per EA (NDC 00591036901), effective Jun 24, 2026.
How has the price of LOXAPINE 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOXAPINE 5 MG CAPSULE has declined 11.9%. It has been tracked across 600 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOXAPINE 5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for LOXAPINE 5 MG CAPSULE has ranged from a low of $0.2375 (Jan 22, 2025) to a high of $0.5044 (Dec 13, 2023), with a median of $0.3527 per EA.
Are there cheaper alternatives to LOXAPINE 5 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LOXAPINE 5 MG CAPSULE, but none are currently priced below it.
Who manufactures LOXAPINE 5 MG CAPSULE?
LOXAPINE 5 MG CAPSULE (NDC 00591036901) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification